Read Larry Connors' blog – Short Term Trading Strategies
The lawsuit, Gary A. Rowlett and Roxie A. Rowlett v. Bayer Corporation, et al., was filed in the United States District Court for the Southern District of Florida. The patient, Gary A. Rowlett experienced renal failure after aortic valve replacement where Trasylol (Aprotinin), a drug used to minimize intraoperative bleeding, was administered. A case filed earlier by Napoli Bern Ripka & Associates, Randone v. Bayer, was the subject of a profile on the CBS newsmagazine "60 Minutes," on February 17, 2008, entitled "One Thousand Lives A Month." Mr. Randone suffered kidney failure and other serious complications caused by his physicians' use of Trasylol that ultimately resulted in his death.
The Ottawa Health Research Institute stopped their study of Trasylol in 3,000 heart bypass and valve surgery patients, upon their finding that while those given the drug suffered less intraoperative bleeding, they had a 50% higher chance of dying post surgically than those patients who were given one or another of two older medical alternatives. Dr. John K. Jenkins, an official of the Food and Drug Administration, said the "F.D.A. could not identify a specific patient population where the benefits of using Trasylol could outweigh the risks." The F.D.A. said that the fact that the Ottawa group ended their study early was a strong factor in their decision to request that Bayer withdraw the drug from the market.
About the Firm:
Napoli Bern Ripka & Associates, LLP, a nationally-known law firm advocating on behalf of injured plaintiffs in pharmaceutical and environmental tort matters, is based in Manhattan and Great River, New York, and has offices in Philadelphia, New Jersey, and Oklahoma. The firm has successfully litigated claims of thousands of persons injured by the diet drugs Fenfluramine and dexfenfluramine (Reduxtm), Rezulin, Propulsid and represents clients in environmental claims arising from petroleum spills and MTBE contamination throughout the eastern United States, as well as over ten thousand plaintiffs suffering toxic exposure injuries after working on the debris pile at the site of the World Trade Center following the September 11, 2001 attacks.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Napoli Bern Ripka, LLP
Napoli Bern Ripka & Associates, LLP
Marc Jay Bern, Esq.
(212) 267-3700
mjbern@napolibern.com
3500 Sunrise Hwy., Suite T-207
Great River, New York 11739
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.